xanomeline has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bymaster, FP; Calligaro, DO; Deeter, JB; Merritt, L; Mitch, CH; Olesen, PH; Peters, SC; Sauerberg, P; Sawyer, BD; Shannon, HE; Sheardown, MJ; Swedberg, MD; Ward, JS | 1 |
Christopoulos, A; Felder, CC; Leach, K; Nawaratne, V; Sexton, PM | 1 |
Chen, H; Hou, Y; Wang, D; Wang, H; Wang, S; Xu, J; Yao, Y; Zhao, L | 1 |
3 other study(ies) available for xanomeline and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Article | Year |
---|---|
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Male; Mice; Muscarinic Agonists; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Structure-Activity Relationship; Thiadiazoles | 1995 |
Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Allosteric Site; Animals; Cricetinae; Humans; Ligands; Models, Biological; Mutagenesis; Mutagenesis, Site-Directed; Protein Binding; Pyridines; Receptor, Muscarinic M4; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship; Thiadiazoles | 2010 |
Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; Energy Transfer; GTP-Binding Proteins; HEK293 Cells; Humans; Molecular Docking Simulation; Pilocarpine; Receptor, Muscarinic M1 | 2023 |